Related Experiment Video
Updated: Feb 11, 2026

Robot-Assisted Kidney Transplantation
Published on: July 19, 2021
Factors Associated With Waiting Time to Deceased Donor Kidney Transplantation in Transplant Candidates
1Transplant Center, Seoul National University Hospital, Seoul, Republic of Korea.
Insights
Longer deceased donor kidney transplant waiting times in Korea are linked to non-AB blood types, positive panel-reactive antibody (PRA) levels, and adult age. Strategies like desensitization are needed for highly sensitized patients to reduce wait times.
Area of Science:
- Nephrology
- Transplant Surgery
- Immunology
Background:
- Deceased donor kidney transplantation (DDKT) is crucial for end-stage renal disease, but donor supply-demand imbalance leads to prolonged waiting times in Korea.
- Despite a nationwide activation system, significant discrepancies persist, necessitating an analysis of current waiting times and associated risk factors.
Purpose of the Study:
- To determine the current status of waiting times for deceased donor kidney transplantation (DDKT).
- To identify risk factors contributing to prolonged waiting times for DDKT in Korea.
Main Methods:
- Retrospective analysis of medical records for patients on the DDKT wait list at Seoul National University Hospital (2000-2017).
- Evaluation of factors including blood type, panel-reactive antibody (PRA) levels, age, and transplant history.
Main Results:
- Out of 2,211 wait-listed patients, 606 (27.5%) received DDKT with a mean waiting time of 45 months.
- Positive PRA recipients experienced longer waiting times (63-66 months) compared to PRA-negative recipients (42.8 months).
- Non-AB blood types (46 months) and adult age were associated with longer waiting times than blood type AB (39 months) and pediatric recipients.
Conclusions:
- Non-AB blood type, positive PRA, and adult age are significant risk factors for extended DDKT waiting times.
- Management strategies, including tailored desensitization for highly sensitized patients, are essential to reduce waiting times and improve transplant access.
Abstract:
Although a nationwide activation system has been developed to increase deceased donor kidney transplantation (DDKT), there is still enormous discrepancy between transplant need and deceased donor supply in Korea, and therefore waiting time to DDKT is still long. We need to determine the current status of waiting time and the risk factors for long waiting time. We retrospectively analyzed the medical records of the patients on the wait list for DDKT at the Seoul National University Hospital from 2000 to 2017. Among 2,211 wait-listed patients, 606 (27.5%) received DDKT and mean waiting time to DDKT was 45 months. Among them, blood type A was most prevalent (35.6%) and type AB was the least (14.0%). Panel-reactive assay (PRA) was positive in 59 (11.0%) in the first transplant group and 25 (35.0%) in retransplant group. Waiting time in PRA-positive recipients was 63 and 66 months in the first transplant group and retransplant group, respectively. However, waiting time for patients with negative PRA was 42.8 months. Waiting time was shorter in blood type AB (39 months) than other types (46 months). Waiting time was the shortest in children and adolescents. Among patients who were still on the wait list, retransplantation candidates, especially with PRA higher than 50%, had longer waiting time than first transplant candidates. In conclusion, non-AB blood type, positive PRA, and adult age were significantly associated with long waiting time. Therefore, it is necessary to establish a management strategy such as tailored desensitization for highly sensitized patients on the wait list to reduce their waiting time.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Structure

